Sage Therapeutics (SAGE)
149.46
-0.71 -0.47%
NASDAQ
Aug 15, 10:24
Delayed 2m
USD
View All Key Stats
SAGE Key Stats
| Income Statement | |
| Revenue (TTM) | -- |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -5.73 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -234.72M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -18.86% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 6.974B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | -- |
| PE Ratio (TTM) | -- |
| Price to Book Value | 6.471 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | -0.537M |
| Return on Equity (TTM) | Upgrade |
View All SAGE News
SAGE News
-
WireHeadlineTime (ET)
-
Yahoo08/13 10:16
-
Yahoo08/13 07:00
-
SA Breaking News08/07 07:50
-
MT Newswires08/07 07:41
-
SA Breaking News08/07 06:32
-
Business Wire08/07 06:30
-
Yahoo08/07 06:00
-
SA Breaking News08/06 17:30
-
SA Breaking News08/06 07:57
-
Business Wire08/03 06:30
View All Events
SAGE Events
| Date | Type | Description |
|---|---|---|
| 11/02/2018 08:00 EDT | Misc | Sage Therapeutics Inc Third Quarter Earnings Conference Call in 2018 |
| 11/02/2018 | Earnings | Sage Therapeutics Inc Third Quarter Earnings in 2018 Release |
| 08/07/2018 08:00 EDT | Misc | Sage Therapeutics Inc Second Quarter Earnings Conference Call in 2018 |
| 08/07/2018 | Earnings | Sage Therapeutics Inc Second Quarter Earnings Results in 2018 |
| 06/06/2018 | Misc | Sage Therapeutics Inc Annual General Meeting in 2017 |
| 05/03/2018 08:00 EDT | Misc | Sage Therapeutics Inc First Quarter Earnings Conference Call in 2018 |
| 05/03/2018 | Earnings | Sage Therapeutics Inc First Quarter Earnings in 2018 Release |
| 02/22/2018 08:00 EST | Misc | Sage Therapeutics Inc Fourth Quarter Earnings Conference Call in 2017 |
| 02/22/2018 | Earnings | Sage Therapeutics Inc Fourth Quarter Earnings Results in 2017 |
| 11/02/2017 08:00 EDT | Misc | Sage Therapeutics Inc Third Quarter Earnings Conference Call in 2017 |
SAGE Fundamentals
Income Statement View Statement
SAGE Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
SAGE One Page Reports
- One Page Report Download
SAGE Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 149.46 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.sagerx.com
- Investor Relations URL: http://investor.sagerx.com/
- HQ State/Province: Massachusetts
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Mid Cap/Blend
- Next Earnings Release: Nov. 02, 2018
- Last Earnings Release: Aug. 07, 2018
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Sage Therapeutics Inc is a biopharmaceutical company conducting development programs and clinical trials to discover medicines for central nervous system disorders. It has development programs for refractory status epilepticus, and Parkinson's di-sease.
SAGE Excel Add-In Codes
- Name: =YCI("SAGE","name")
- Description: =YCI("SAGE","description")
- Sector: =YCI("SAGE","sector")
- Industry: =YCI("SAGE","industry")
- Est. Current Fiscal Year End: =YCI("SAGE","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other SAGE Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- SAGE Tweets Stocktwits
Advertisement
